Overview
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2025-07-01
2025-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Fernando BacalTreatments:
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Hospitalized patients submitted to orthotopic heart transplantation (HT)
Exclusion Criteria:
- Requirement of renal replacement therapy before HT
- Requirement of extracorporeal membrane oxygenation (ECMO) before HT
- Double transplant (e.g. heart-kidney or heart-lung)
- Hypernatremia (Na ≥ 145)
- Moderate or severe hyponatremia (Na ≤ 120)